pMSCV-Cas9-2A-GFP-sgRNA Citations (3)

Originally described in: Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells.
Li H, Shi J, Huang NJ, Pishesha N, Natarajan A, Eng JC, Lodish HF Haematologica. 2016 Jun;101(6):e216-9. doi: 10.3324/haematol.2015.135723. Epub 2016 Mar 11. PubMed Journal

---

Articles Citing pMSCV-Cas9-2A-GFP-sgRNA

Articles
Myeloid transformation by MLL-ENL depends strictly on C/EBP. Wesolowski R, Kowenz-Leutz E, Zimmermann K, Dorr D, Hofstatter M, Slany RK, Mildner A, Leutz A. Life Sci Alliance. 2020 Nov 3;4(1). pii: 4/1/e202000709. doi: 10.26508/lsa.202000709. Print 2021 Jan. PubMed
Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells. Laffleur B, Lim J, Zhang W, Chen Y, Pefanis E, Bizarro J, Batista CR, Wu L, Economides AN, Wang J, Basu U. Nat Genet. 2021 Feb;53(2):230-242. doi: 10.1038/s41588-020-00772-0. Epub 2021 Feb 1. PubMed
Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators. Le TA, Chu VT, Lino AC, Schrezenmeier E, Kressler C, Hamo D, Rajewsky K, Dorner T, Dang VD. Mol Ther Nucleic Acids. 2022 Nov 21;30:621-632. doi: 10.1016/j.omtn.2022.11.016. eCollection 2022 Dec 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.